Subscribe now

Just look at what’s going on with mRNA injections

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

BioNTech/Roche mRNA Therapy for Pancreatic Cancer Inspires Early Optimism

Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise

Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study

Sanofi launches dedicated vaccines mRNA Center of Excellence

Bayer to manufacture mRNA vaccine in Germany

Some of the world’s largest pharmaceutical product sellers are into mRNA in a big way; also, two of the world’s tiniest pharmaceutical product sellers (by #employed), are also in the mix.

What’s noticeable is that they all seem to be collaborating and sharing various business opportunities with each other—why would that be?

I’m all in favour of strategic collaboration with third party businesses to increase competitiveness, but this seems a completely random way of doing business.

Hold that thought while we dig a bit deeper. We begin with the Bill and Melinda Gates Foundation (BMGF).

Note from Hedley: On Friday, it will be INSIDE PHARMA’s first birthday. Nearly all of the posts have been free, but as things have progressed, I am having to put an enormous amount of time into keeping peeps updated, so there will be less free content in the future. Be assured, I am sharing everything I know in expert statements that have gone, or are going, to people and entities that I trust, across UK, EU, US. I like to think my perspective brings much needed ‘grass roots’ knowledge and information to the fight against the evil jabs—so please do not feel offended if you wish to remain a free subscriber—this will all ‘out’ in the not too distant future.

INSIDE PHARMA

Bill & Melinda Gates Foundation is now Global…

Keep reading with a 7-day free trial